Hikma Pharmaceuticals expects sales to pick up in 2020, helped by its injectables drugs division. Salah Malkawi/ The National
Hikma Pharmaceuticals expects sales to pick up in 2020, helped by its injectables drugs division. Salah Malkawi/ The National
Hikma Pharmaceuticals expects 2020 sales growth after posting 10% profit rise
Drugmaker does not foresee "any material impact" to its business from the coronavirus outbreak
